Motens 2mg tablets

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Lacidipine

Доступна с:

GlaxoSmithKline UK Ltd

код АТС:

C08CA09

ИНН (Международная Имя):

Lacidipine

дозировка:

2mg

Фармацевтическая форма:

Oral tablet

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 02060200; GTIN: 5012816085053

тонкая брошюра

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU_._
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
pharmacist.
• This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their signs
of illness are the same as yours.
• If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet.
WHAT IS IN THIS LEAFLET:
1 What Motens is and what it is used for
2 What you need to know before you take Motens
3 How to take Motens
4 Possible side effects
5 How to store Motens
6 Contents of the pack and other information
1. WHAT MOTENS IS AND WHAT IT IS USED FOR
Motens contains a medicine called lacidipine. This belongs
to a group of medicines called ‘calcium channel blockers’.
Motens helps to relax your blood vessels so that they get
wider. This helps the blood to flow more easily and lowers
the blood pressure.
Motens tablets taken regularly as prescribed by your
doctor will help to lower your blood pressure (to treat
hypertension).
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE MOTENS
DO NOT TAKE MOTENS IF:
• You are pregnant, likely to get pregnant or are
breast-feeding
• You are allergic (hypersensitive) to lacidipine, other
calcium channel blocker medicines or any of the other
ingredients of this medicine (listed in section 6)
• You have the heart problem ‘aortic stenosis’. This is a
narrowing of a valve in your heart, which restricts blood
flow
• You have had a heart attack within the last month
Do not take if any of the above apply to you. If you are not
sure, talk to your doctor or pharmacist before taking Motens.
• You should stop taking Motens if you get chest pain
(angina) or a fast, weak pulse, rapid shallow breathing,
low blood pressure, cold clammy skin, blue lips or feel
dizzy, faint, weak or sick
TAKE SPECIAL CARE WITH MOTENS
Check with your doctor or p

Характеристики продукта

1
NAME OF THE MEDICINAL PRODUCT
Motens 2 mg Tablets.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tablets containing lacidipine 2 mg.
Excipient with known effect:
Lactose 277.25 mg per tablet.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film coated tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
MOTENS is indicated for the treatment of hypertension either alone or
in
combination
with
other
antihypertensive
agents,
including
β
-adrenoceptor
antagonists, diuretics, and ACE-inhibitors.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_ADULTS: _
The treatment of hypertension should be adapted to the severity of the
condition, and
according to the individual response.
The recommended initial dose is 2 mg once daily. The dose may be
increased to 4 mg
(and then, if necessary, to 6 mg) after adequate time has been allowed
for the full
pharmacological effect to occur. In practice, this should not be less
than 3 to 4 weeks.
Daily doses above 6 mg have not been shown to be significantly more
effective.
MOTENS should be taken at the same time each day, preferably in the
morning.
Treatment with MOTENS may be continued indefinitely.
_PATIENTS WITH HEPATIC IMPAIRMENT: _
Lacidipine is metabolised primarily by the liver and therefore in
patients with hepatic
impairment, the bioavailability of MOTENS may be increased and the
hypotensive
effect enhanced. These patients should be carefully monitored, and in
severe cases, a
dose reduction may be necessary.
_ _
_PATIENTS WITH KIDNEY DISEASE: _
As MOTENS is not cleared by the kidneys, the dose does not require
modification in
patients with kidney disease.
_ _
_PAEDIATRIC POPULATION: _
No experience has been gained with MOTENS in children.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1.
MOTENS should only be used with great care in patients with a previous
allergic
reaction to another dihydropyridine because there is a theoretical
r